We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesOrthofix Medical Inc

Orthofix Medical Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
7.13 USD -0.05 ( 0.70%)
Last update at 2026-11-12T15:42:00Z
VOLUME
60999
Market Cap
370.26M

Momentum Score

…

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
7.12
Low
7.31
High
52 Week Price Range
8.62
Low
16.99
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
7.18
Dividend Yield
-
Revenue TTM
833.19M
Revenue Per Share
20.68
Gross Profit TTM
593.73M
Debt / Equity
0.51
ROE
-13.91%
Net Debt
147.24M
ROCE
-10.78%
Diluted EPS TTM
-1.52

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -90.81M -123.88M -148.68M -17.71M -13.49M
Net income -92.19M -126.00M -151.40M -19.75M -38.38M
Selling general administrative 554.33M 532.52M 144.66M 79.97M 69.35M
Selling and marketing expenses - - 385.74M 228.81M 221.32M
Gross profit 551.71M 545.88M 486.27M 337.17M 349.56M
Reconciled depreciation 83.25M 76.00M 60.60M 32.08M 33.09M
Ebit -73.32M -94.24M -140.05M -20.67M -6.23M
Ebitda -22.35M -34.18M -79.49M -23.82M 26.86M
Depreciation and amortization 50.97M 60.06M 60.56M -3.15M 33.09M
Non operating income net other - - - -2.75M -4.29M
Operating income -68.47M -84.62M -139.11M -20.67M -6.23M
Other operating expenses 890.78M 884.11M 885.75M 481.38M 455.21M
Interest expense 17.49M 29.63M 8.63M 1.29M 1.84M
Tax provision 1.38M 2.12M 2.72M 2.04M 24.88M
Net interest income -17.49M -29.63M -8.63M -1.29M -1.84M
Income tax expense 1.38M 2.12M 2.72M 2.04M 24.88M
Total revenue 822.31M 799.49M 746.64M 460.71M 464.48M
Total operating expenses 620.18M 630.50M 625.38M 357.84M 340.29M
Cost of revenue 270.61M 253.61M 260.37M 123.54M 114.91M
Total other income expense net -22.34M -39.26M -9.57M 2.97M -7.26M
Net income from continuing ops -92.19M -126.00M -151.40M -19.75M -38.38M
Net income applicable to common shares - - - -19.75M -38.38M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 850.65M 893.29M 925.32M 458.63M 476.62M
Intangible assets 72.77M 98.80M 117.49M 47.39M 52.67M
Other current assets 164.91M 25.88M 32.42M 22.28M 20.14M
Total liab 400.61M 390.17M 326.58M 121.77M 139.69M
Total stockholder equity 450.04M 503.12M 598.73M 336.86M 336.93M
Deferred long term liab - - - 0.70M 1.00M
Other current liab 108.11M 106.63M 101.43M 55.37M 76.78M
Common stock 3.98M 3.85M 3.72M 2.02M 1.98M
Capital stock 3.98M 3.85M 3.72M 2.02M 1.98M
Retained earnings -368.33M -276.14M -150.14M 1.25M 21.00M
Other liab - - - 13.53M 13.97M
Good will 194.93M 194.93M 194.93M 71.32M 71.32M
Other assets - 398.54M - 12.83M 23.87M
Cash 82.03M 83.24M 37.76M 50.70M 87.85M
Total current liabilities 170.48M 168.63M 165.22M 83.62M 105.83M
Net debt 147.24M 96.39M 96.44M -30.81M -65.37M
Short term debt 3.98M 4.78M 5.43M 0.65M 2.59M
Short long term debt - - 1.25M - -
Short long term debt total 229.26M 179.63M 134.20M 19.89M 22.48M
Other stockholder equity 813.77M 779.72M 746.45M 334.97M 313.95M
Property plant equipment - - - 58.23M 59.25M
Total current assets 416.85M 433.29M 420.44M 255.99M 269.52M
Net tangible assets - - - 218.16M 212.95M
Net receivables 135.75M 134.71M 128.10M 82.86M 78.56M
Long term debt 157.39M 157.01M 93.11M - -
Inventory 34.17M 189.45M 222.17M 100.15M 82.97M
Accounts payable 58.39M 48.80M 58.36M 27.60M 26.46M
Accumulated other comprehensive income 0.62M -4.30M -1.29M -1.38M -
Common stock total equity - - - 2.02M 1.98M
Retained earnings total equity - - - 1.25M 21.00M
Non currrent assets other -77.44M 26.47M 11.14M 25.70M 22.09M
Non current assets total 433.80M 460.01M 504.87M 202.64M 207.10M
Capital lease obligations 21.04M 22.61M 22.72M 21.53M 24.31M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 0.00M -27.58M -33.13M -24.53M -2.17M
Change to liabilities - - - 2.91M 5.27M
Total cashflows from investing activities -34.60M -27.58M - -24.53M -23.01M
Net borrowings -0.76M 54.39M - -0.09M -0.95M
Total cash from financing activities -0.79M 50.71M 65.32M -0.08M -3.62M
Change to operating activities - - - -1.86M -13.46M
Net income -92.19M -126.00M -151.40M -19.75M -38.38M
Change in cash -0.62M 47.98M -12.94M -37.15M -8.97M
Begin period cash flow 85.74M 37.76M 50.70M 87.85M 96.82M
End period cash flow 85.11M 85.74M 37.76M 50.70M 87.85M
Total cash from operating activities 33.35M 25.79M -45.75M -11.54M 18.48M
Issuance of capital stock 5.93M 6.26M 5.13M 4.34M 8.82M
Depreciation 83.25M 75.96M 53.06M 32.08M 33.09M
Other cashflows from investing activities 0.03M -0.10M - -3.17M -3.06M
Dividends paid - - - 1.73M 2.56M
Change to inventory -10.75M -5.55M -58.05M -18.13M 0.62M
Change to account receivables -1.58M -9.53M -10.41M -6.74M -7.05M
Sale purchase of stock - - -4.40M -1.73M -2.56M
Other cashflows from financing activities -5.95M -9.94M 128.14M 1.64M -6.80M
Change to netincome - - - 5.68M 49.60M
Capital expenditures 34.63M 34.88M 62.05M 23.16M 19.59M
Change receivables - - - -6.74M -7.05M
Cash flows other operating - - - -4.53M -21.18M
Cash and cash equivalents changes - - - -36.15M -8.16M
Change in working capital -21.50M -19.25M -53.96M -29.23M -18.10M
Stock based compensation 28.69M 32.45M 35.71M 18.44M 15.43M
Other non cash items 34.87M 60.74M 70.26M -13.39M 1.95M
Free cash flow -1.28M -9.09M -107.80M -34.70M -1.12M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
OFIX
Orthofix Medical Inc		 -0.05
0.70%		 7.13 - 500.00 0.44 0.86 0.60 26.44
ABT
Abbott Laboratories		 -0.71
0.65%		 108.58 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 0.28
0.28%		 101.89 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -2.16
0.68%		 316.63 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 -
-%		 47.31 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Orthofix Medical Inc

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

3451 Plano Parkway, Lewisville, TX, United States, 75056

214 937 2000

https://orthofix.com

1605

Name Title Year Born
Mr. Jon C. Serbousek Pres, CEO & Director 1961
Mr. Douglas C. Rice CFO & Chief Accounting Officer 1966
Ms. Kimberley A. Elting Chief Legal & Devel. Officer and Pres of the Global Orthopedics 1965
Mr. Kevin J. Kenny Pres of Global Spine Bus. 1965
Mr. Roberto Donadello Sr. VP of Global Operations NA
Dr. James T. Ryaby B.A., Chemistry, Ph.D. Chief Scientific Officer 1959
Mr. Dan E. Yarbrough VP of Investor Relations NA
Ms. Suzanne Armstrong Sr. VP of HR NA
Mr. Ehab M. Esmail Sr. VP of Quality, Regulatory & Clinical Affairs 1972
Mr. Mark Quick Sr. Director of Bus. Devel. & Investor Relations NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CJT
CAD 111.15
+12.71%
CLS
CAD 374.20
+8.33%
GRZ
CAD 4.90
+7.46%
CTC-A
CAD 218.05
+6.38%
FEC
CAD 7.42
+5.85%
TF
CAD 4.13
-19.65%
TLO
CAD 5.98
-15.06%
FSZ
CAD 2.45
-14.04%
XNDU
CAD 3.60
-8.86%
ITR
CAD 2.75
-8.50%

Equity Sectors*

  • Basic Materials

    -2.63%

  • Communication Services

    -0.79%

  • Consumer Cyclical

    +0.08%

  • Consumer Defensive

    -0.12%

  • Energy

    +0.52%

  • Financial Services

    -1.15%

  • Healthcare

    -1.74%

  • Industrials

    -0.64%

  • Real Estate

    -0.12%

  • Technology

    -0.51%

  • Utilities

    -0.02%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…